Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus

Clinical Rheumatology
Araceli Garcia-GonzalezMaria E Suarez-Almazor

Abstract

This study assessed self-reported adherence in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) from underserved healthcare settings. We conducted a cross-sectional survey of 102 ethnically diverse patients--70 with RA and 32 with SLE--attending rheumatology clinics at publicly funded hospitals in Houston, Texas; 43% were Hispanic, 32% African-American, and 25% White. Treatment adherence was evaluated using the compliance questionnaire rheumatology (CQR; 0, low adherence and 100, high adherence) and the questionnaire of the Adult AIDS Clinical Trials Group (AACTG). The patients were also asked how often they forgot to take their prescribed medications or discontinued them on their own. Mean patient age was 48.5 years; 75% were female, 32% were African-American, 43% Hispanic, and 25% White. Only one third reported never forgetting to take their medications; 40% reported having stopped their medications on their own because of side effects, and 20% because of lack of efficacy. Mean CQR score was 69.1 +/- 10.5, suggesting moderate adherence overall. Differences were also observed across ethnic groups: 23% of ethnic minority patients had problems taking their medications at specified times compared to ...Continue Reading

Associated Clinical Trials

References

Jun 1, 1979·Australian and New Zealand Journal of Medicine·P Lee, L J Tan
Oct 1, 1991·The American Journal of Medicine·M PetriM Hochberg
Feb 1, 1991·Research in Nursing & Health·E A Graveley, C S Oseasohn
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Nov 24, 1999·American Journal of Hypertension·M N HillD M Levine
Mar 8, 2000·International Journal of Clinical Pharmacology and Therapeutics·L P Balant, E A Balant-Gorgia
Jan 11, 2003·Arthritis and Rheumatism·Angelia Mosley-WilliamsDeena Guice
Jun 4, 2004·Quality & Safety in Health Care·N BarberR Horne
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke

❮ Previous
Next ❯

Citations

May 16, 2009·Journal of Neurology·Katherine TreadawayElliot M Frohman
Aug 10, 2012·Clinical Rheumatology·Lucie HromadkovaJiri Vlcek
Jan 15, 2013·Clinical Rheumatology·Delesha M CarpenterRobert F Devellis
Nov 19, 2013·Best Practice & Research. Clinical Rheumatology·Nathalie Costedoat-ChalumeauJean-Charles Piette
Jul 20, 2011·Health Care for Women International·Ann Miles
Aug 3, 2010·International Journal of Clinical Rheumatology·Sofia de Achaval, Maria E Suarez-Almazor
May 27, 2014·La Presse médicale·Zoubida Tazi Mezalek, Wafaa Bono
Feb 4, 2012·Current Rheumatology Reports·Melissa S Tesher, Karen B Onel
Jul 10, 2012·Current Rheumatology Reports·Christine A McBurney, Ernest R Vina
Jul 14, 2009·Best Practice & Research. Clinical Rheumatology·Kanta KumarCaroline Gordon
Sep 24, 2010·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Colleen A McHorney, Charles V Spain
Mar 13, 2012·Alimentary Pharmacology & Therapeutics·J R GoodhandD S Rampton
Jan 24, 2012·Drug Development Research·Elizabeth Salt, Susan K Frazier
Apr 15, 2010·Arthritis Care & Research·Pantelis PanopalisEdward Yelin
May 13, 2010·Arthritis Care & Research·S Louis BridgesDésirée M van der Heijde
Jun 18, 2015·Journal of Evaluation in Clinical Practice·Lucie HromadkovaJiri Vlcek
Jul 15, 2015·Arthritis Research & Therapy·Irazú Contreras-Yáñez, Virginia Pascual-Ramos
Nov 27, 2014·Rheumatology International·Amal B Abdul-Sattar, Sahar A Abou El Magd
Sep 4, 2016·Rheumatology International·Sebastian BrueraMaria A Lopez-Olivo
Apr 19, 2016·International Journal of Clinical Rheumatology·María F Marengo, María E Suarez-Almazor
Jan 17, 2015·The Journal of Rheumatology·Veronika RauscherAxel J Hueber
Nov 17, 2010·The Journal of Rheumatology·Sasha BernatskyUNKNOWN Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS)
Jun 20, 2017·International Journal of Rheumatic Diseases·Alireza KhabbaziSousan Kolahi
Oct 10, 2018·Musculoskeletal Care·Jan BrijsEllen De Langhe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.